Juraj Benca

696 total citations
42 papers, 487 citations indexed

About

Juraj Benca is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Juraj Benca has authored 42 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Juraj Benca's work include Cancer Cells and Metastasis (16 papers), Bacterial Infections and Vaccines (8 papers) and Metastasis and carcinoma case studies (5 papers). Juraj Benca is often cited by papers focused on Cancer Cells and Metastasis (16 papers), Bacterial Infections and Vaccines (8 papers) and Metastasis and carcinoma case studies (5 papers). Juraj Benca collaborates with scholars based in Slovakia, United States and Malaysia. Juraj Benca's co-authors include Marián Karaba, Michal Mego, Gabriel Minárik, Tatiana Sedláčková, Daniel Pinďák, Jozef Mardiak, Zuzana Čierna, James M. Reuben, Paulina Gronesova and Ľ Danihel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Juraj Benca

34 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juraj Benca Slovakia 13 260 223 209 63 60 42 487
Ludi Yang China 14 243 0.9× 339 1.5× 232 1.1× 63 1.0× 80 1.3× 40 636
Magdalena Frydrychowicz Poland 9 98 0.4× 229 1.0× 135 0.6× 54 0.9× 117 1.9× 25 438
Meiying Shen China 11 147 0.6× 187 0.8× 126 0.6× 50 0.8× 90 1.5× 42 413
Shengkui Tan China 13 151 0.6× 261 1.2× 136 0.7× 71 1.1× 75 1.3× 54 482
Miguel Marino United States 4 192 0.7× 155 0.7× 102 0.5× 44 0.7× 28 0.5× 4 467
Jia-Ling Huang China 9 131 0.5× 301 1.3× 256 1.2× 25 0.4× 58 1.0× 9 465
Alberto Cedro‐Tanda Mexico 11 79 0.3× 238 1.1× 214 1.0× 48 0.8× 50 0.8× 24 395
Yanan Gao China 9 165 0.6× 199 0.9× 100 0.5× 82 1.3× 195 3.3× 11 505
Ryan Erwert United States 6 366 1.4× 309 1.4× 159 0.8× 39 0.6× 122 2.0× 10 610

Countries citing papers authored by Juraj Benca

Since Specialization
Citations

This map shows the geographic impact of Juraj Benca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juraj Benca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juraj Benca more than expected).

Fields of papers citing papers by Juraj Benca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juraj Benca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juraj Benca. The network helps show where Juraj Benca may publish in the future.

Co-authorship network of co-authors of Juraj Benca

This figure shows the co-authorship network connecting the top 25 collaborators of Juraj Benca. A scholar is included among the top collaborators of Juraj Benca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juraj Benca. Juraj Benca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mego, Michal, Barbora Vlková, Gabriel Minárik, et al.. (2022). Vitamin D and circulating tumor cells in primary breast cancer. Frontiers in Oncology. 12. 950451–950451. 6 indexed citations
2.
Karaba, Marián, Gabriel Minárik, Juraj Benca, et al.. (2020). Circulating tumor cells and drug history in primary breast cancer patients. Cancer Drug Resistance. 3(1). 98–109.
3.
Miklikova, Svetlana, Gabriel Minárik, Tatiana Sedláčková, et al.. (2020). Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer. Cancers. 12(5). 1134–1134. 26 indexed citations
4.
Mego, Michal, Marián Karaba, Gabriel Minárik, et al.. (2019). Circulating Tumor Cells With Epithelial–to–mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer. Anticancer Research. 39(4). 1829–1837. 52 indexed citations
7.
Bystrický, Branislav, Marián Karaba, Gabriel Minárik, et al.. (2017). Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer. Anticancer Research. 37(4). 1787–1791. 5 indexed citations
8.
Bystrický, Branislav, Zuzana Čierna, Pavol Janega, et al.. (2017). Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients. Anticancer Research. 37(5). 2727–2734. 10 indexed citations
9.
Smolková, Božena, Michal Mego, Zuzana Čierna, et al.. (2016). Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood. Translational Oncology. 9(3). 184–190. 12 indexed citations
10.
Mego, Michal, Dana Cholujová, Gabriel Minárik, et al.. (2016). CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer. BMC Cancer. 16(1). 127–127. 58 indexed citations
11.
Mego, Michal, Zuzana Čierna, Pavol Janega, et al.. (2015). Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer. BMC Cancer. 15(1). 533–533. 28 indexed citations
12.
Fridrichová, Ivana, Božena Smolková, Iveta Zmetakova, et al.. (2015). CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers. Translational research. 165(6). 717–730. 29 indexed citations
13.
Zmetakova, Iveta, Ľ Danihel, Božena Smolková, et al.. (2013). Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer. Neoplasma. 60(6). 635–646. 32 indexed citations
14.
Benca, Juraj. (2012). Infectious diseases in orphanages in South-east Asia. International Journal of Infectious Diseases. 16. e6–e6.
15.
Benca, Juraj, et al.. (2007). Clinical symptoms, treatment and outcome of highlands malaria in Eldoret (2420 m a.s.l.) and comparison to malaria in hyper-immune population in endemic region of Southern Sudan.. PubMed. 28 Suppl 3. 35–6. 7 indexed citations
16.
Benca, Juraj, et al.. (2007). Ten years experience with 497 cases of neuroinfections in tropic: in limited laboratory infrastructure initially treat both, cerebral malaria and meningitis.. PubMed. 28 Suppl 2. 49–50. 1 indexed citations
17.
Okoth, Vincent, et al.. (2007). Meningococcal meningitis is still the commonest neuroinfection in the community in tropics: overview of 62 cases.. PubMed. 28 Suppl 3. 23–4. 2 indexed citations
18.
Benca, Juraj, et al.. (2007). Nosocomial meningitis caused by Enterobacteriaceae: risk factors and outcome in 18 cases in 1992-2007.. PubMed. 28 Suppl 2. 27–9. 3 indexed citations
19.
Mrázová, M, et al.. (2005). Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes. Scandinavian Journal of Infectious Diseases. 37(9). 637–641. 14 indexed citations
20.
Ondrusova, A, et al.. (1998). Nosocomial meningitis in neonates caused by Streptococcus agalactiae.. PubMed. 23(5). 30–1.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026